PAMU

Pictet Asset Management (UK) Portfolio holdings

AUM $91.6B
1-Year Est. Return 47.77%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+47.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$91.6B
AUM Growth
+$8.53B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,883
New
Increased
Reduced
Closed

Top Buys

1 +$221M
2 +$188M
3 +$168M
4
LULU icon
lululemon athletica
LULU
+$150M
5
WRK
WestRock Company
WRK
+$144M

Top Sells

1 +$550M
2 +$241M
3 +$204M
4
LRCX icon
Lam Research
LRCX
+$167M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$136M

Sector Composition

1 Technology 28.95%
2 Healthcare 15.55%
3 Industrials 13.08%
4 Consumer Discretionary 9.94%
5 Utilities 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOOR
1751
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-1,800
AJRD
1752
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-5,700
RP
1753
DELISTED
RealPage, Inc.
RP
-7,000
CADE
1754
DELISTED
Cadence Bank
CADE
-8,400
CNK icon
1755
Cinemark Holdings
CNK
$3.26B
-10,200
CNO icon
1756
CNO Financial Group
CNO
$3.94B
-11,300
CNNE icon
1757
Cannae Holdings
CNNE
$631M
-6,295
COLB icon
1758
Columbia Banking Systems
COLB
$8.4B
-5,400
COOP
1759
DELISTED
Mr. Cooper
COOP
-6,044
CRDF icon
1760
Cardiff Oncology
CRDF
$131M
-581,907
CVBF icon
1761
CVB Financial
CVBF
$2.61B
-11,500
CWB icon
1762
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.16B
-22,400
DOO
1763
Bombardier Recreational Products
DOO
$5.38B
-3,000
DY icon
1764
Dycom Industries
DY
$12.6B
-2,800
EAT icon
1765
Brinker International
EAT
$6.45B
-3,200
ENTA icon
1766
Enanta Pharmaceuticals
ENTA
$415M
-30,806
ESE icon
1767
ESCO Technologies
ESE
$7.18B
-2,100
LGND icon
1768
Ligand Pharmaceuticals
LGND
$3.9B
-2,244
MGEE icon
1769
MGE Energy Inc
MGEE
$3B
-3,200
MOG.A icon
1770
Moog Inc Class A
MOG.A
$10.7B
-2,600
MTX icon
1771
Minerals Technologies
MTX
$2.2B
-2,700
NSP icon
1772
Insperity
NSP
$838M
-3,000
AAON icon
1773
Aaon
AAON
$8.26B
-4,800
ABCB icon
1774
Ameris Bancorp
ABCB
$5.28B
-5,600
ABUS icon
1775
Arbutus Biopharma
ABUS
$896M
-209,129